NeuroPace (NPCE) Equity Ratio (2020 - 2026)

NeuroPace has reported Equity Ratio for 7 years, with the latest figure at 0.15 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 33.63% year-over-year to 0.15; the trailing twelve-month figure through Mar 2026 stood at 0.15 (down 33.63% YoY), and the FY2025 full-year result was 0.18, up 112.94% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.15, down from 0.18 in the prior quarter.
• The five-year high for Equity Ratio was 0.49 in Q1 2022, with the low at 0.08 in Q4 2024.
• Average Equity Ratio over 5 years is 0.22, with a median of 0.18 recorded in 2025.
• Year-over-year, Equity Ratio surged 115.67% in 2022 and tumbled 55.87% in 2024.
• Tracing NPCE's Equity Ratio over 5 years: stood at 0.3 in 2022, then slumped by 37.05% to 0.19 in 2023, then slumped by 55.87% to 0.08 in 2024, then surged by 112.94% to 0.18 in 2025, then retreated by 18.93% to 0.15 in 2026.
• The last three Equity Ratio figures came in at 0.15 (Q1 2026), 0.18 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.

Peer Comparison